ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-3.43%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$32.1B
AUM Growth
-$2.41B
(-7%)
Cap. Flow
-$971M
Cap. Flow
% of AUM
-3.03%
Top 10 Holdings %
Top 10 Hldgs %
22.71%
Holding
1,901
New
52
Increased
542
Reduced
1,211
Closed
85
Top Buys
| 1 |
Broadcom
AVGO
|
$49.9M |
| 2 |
PepsiCo
PEP
|
$36.1M |
| 3 |
Costco
COST
|
$34.9M |
| 4 |
Trade Desk
TTD
|
$32.3M |
| 5 |
Adobe
ADBE
|
$31.1M |
Top Sells
| 1 |
Microsoft
MSFT
|
$408M |
| 2 |
NVIDIA
NVDA
|
$366M |
| 3 |
Amazon
AMZN
|
$224M |
| 4 |
Apple
AAPL
|
$158M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$146M |
Sector Composition
| 1 | Technology | 26.25% |
| 2 | Industrials | 11.98% |
| 3 | Consumer Staples | 11.35% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Healthcare | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Lyell Immunopharma
LYEL
$233M
| $57.3K | ﹤0.01% |
1,948
+12
| +0.6% | +$353 |
|
1702
Arcutis Biotherapeutics
ARQT
$2.06B
| $56.9K | ﹤0.01% |
10,708
+47
| +0.4% | +$250 |
|
1703
Planet Labs
PL
$1.98B
| $56.8K | ﹤0.01% |
21,851
-2,974
| -12% | -$7.73K |
|
1704
MaxCyte
MXCT
$150M
| $56.5K | ﹤0.01% |
18,120
+87
| +0.5% | +$271 |
|
1705
W&T Offshore
WTI
$261M
| $56K | ﹤0.01% |
12,774
-16
| -0.1% | -$70 |
|
1706
SIGA Technologies
SIGA
$603M
| $55.8K | ﹤0.01% |
10,633
+29
| +0.3% | +$152 |
|
1707
MacroGenics
MGNX
$126M
| $55.7K | ﹤0.01% |
11,955
+38
| +0.3% | +$177 |
|
1708
Community Health Systems
CYH
$409M
| $55.6K | ﹤0.01% |
19,167
-506
| -3% | -$1.47K |
|
1709
Arbutus Biopharma
ABUS
$805M
| $55.2K | ﹤0.01% |
27,170
+188
| +0.7% | +$382 |
|
1710
CleanSpark
CLSK
$2.6B
| $54.7K | ﹤0.01% |
+14,361
| New | +$54.7K |
|
1711
DocGo
DCGO
$155M
| $53.9K | ﹤0.01% |
10,104
-13
| -0.1% | -$69 |
|
|
ME
1712
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $53K | ﹤0.01% |
2,710
+72
| +3% | +$1.41K |
|
1713
GoPro
GPRO
$236M
| $52.8K | ﹤0.01% |
16,813
-21
| -0.1% | -$66 |
|
|
AGEN
1714
Agenus
AGEN
$138M
| $51.4K | ﹤0.01% |
2,275
+44
| +2% | +$994 |
|
1715
Seres Therapeutics
MCRB
$169M
| $50K | ﹤0.01% |
1,051
+5
| +0.5% | +$238 |
|
|
TWKS
1716
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $49.1K | ﹤0.01% |
12,024
-19
| -0.2% | -$78 |
|
1717
Xeris Biopharma Holdings
XERS
$1.27B
| $48.9K | ﹤0.01% |
26,312
+122
| +0.5% | +$227 |
|
1718
Precigen
PGEN
$1.3B
| $48.6K | ﹤0.01% |
34,255
+151
| +0.4% | +$214 |
|
1719
Ocular Therapeutix
OCUL
$2.37B
| $48.1K | ﹤0.01% |
15,319
+153
| +1% | +$480 |
|
1720
Vanda Pharmaceuticals
VNDA
$272M
| $47.9K | ﹤0.01% |
11,098
-1,465
| -12% | -$6.33K |
|
|
SLGC
1721
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $46.9K | ﹤0.01% |
19,635
-23
| -0.1% | -$55 |
|
1722
Nautilus Biotechnolgy
NAUT
$83.5M
| $46.5K | ﹤0.01% |
14,726
+80
| +0.5% | +$253 |
|
1723
Atea Pharmaceuticals
AVIR
$267M
| $46.2K | ﹤0.01% |
15,411
+45
| +0.3% | +$135 |
|
1724
Gannett
GCI
$629M
| $45.9K | ﹤0.01% |
18,744
-22
| -0.1% | -$54 |
|
1725
EVgo
EVGO
$529M
| $44.9K | ﹤0.01% |
+13,275
| New | +$44.9K |
|